Nasdaq:MTEX
MANNATECH INC
A US-based specialty retailer of nutritional supplements and wellness products offering a diverse private label portfolio with improving profitability.
Key Metrics
Investment Thesis
Bull Case
Investors may be attracted by the company's recent return to profitability and strong free cash flow generation which supports dividend potential or share buybacks in the future. The diverse product portfolio across supplements, sports nutrition, and organic foods offers multiple revenue streams that can withstand sector-specific downturns. Valuation metrics appear attractive relative to peers given the turnaround story and the secular growth trend in the global wellness and nutrition market.
Bear Case
Concerns persist regarding the contraction in total revenue over the last three years, which could indicate weakening consumer demand or distribution channel challenges. The significant accumulated other comprehensive loss of $5.7M and a retained earnings deficit suggest lingering equity quality issues that warrant close monitoring by conservative investors. High operating expenses relative to revenue may limit the ability to scale profits rapidly if market conditions deteriorate further in the coming quarters.
About MANNATECH INC
MANNATECH INC operates as a specialty retailer of nutritional supplements, vitamins, minerals, and wellness products primarily serving health-conscious consumers in the United States. The company leverages its extensive private label portfolio to offer high-margin goods across various categories including sports nutrition, herbal supplements, and organic foods. With a strong focus on brand loyalty and direct-to-consumer strategies, MANNATECH aims to capture market share in the growing global wellness industry.
Analysis
Management Discussion
The company successfully turned its profit trajectory around in 2024, achieving $2.5M net income compared to losses in the prior two years, demonstrating operational resilience and effective cost management. Despite a year-over-year revenue decline to $117.9M from 2023 levels, the improved bottom line suggests successful margin expansion strategies are offsetting top-line headwinds. Strong cash flow generation of $2.3M from operations and a healthy ending cash balance of $12.5M provide ample liquidity to navigate economic uncertainties and fund future growth initiatives.
Industry Overview
The global nutritional supplement industry is experiencing robust secular growth driven by increasing health awareness, aging populations, and rising disposable incomes worldwide. Consumers are increasingly seeking natural, organic, and science-backed products, creating opportunities for companies with strong R&D capabilities and clean-label formulations. Regulatory scrutiny remains high as governments globally tighten oversight on health claims and ingredient safety to protect public welfare.
Financial Statements
Income Statement
Balance Sheet
Cash Flow
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | $137.2M | $132.0M | $117.9M |
| Cost of Revenue | $33.1M | $29.1M | $26.4M |
| Gross Profit | $104.1M | $102.9M | $91.5M |
| Operating Expenses | $104.6M | $103.8M | $90.0M |
| Operating Income | $-405.0K | $-964.0K | $1.4M |
| R&D | $1.0M | $800.0K | $700.0K |
| G&A | $27.5M | $48.6M | $41.7M |
| Marketing | — | — | $19.7M |
| Stock-Based Comp | $337.0K | $278.0K | $291.0K |
| D&A | $1.6M | $1.6M | $1.5M |
| Other OpEx | $76.1M | $54.4M | $27.9M |
| Non-Operating Income | $-74.0K | $-166.0K | $2.3M |
| Pre-Tax Income | $-479.0K | $-1.1M | $3.7M |
| Income Tax | $4.0M | $1.1M | $1.2M |
| Continuing Ops | $-4.5M | $-2.2M | $2.5M |
| Discontinued Ops | $0 | $0 | $0 |
| Net Income | $-4.5M | $-2.2M | $2.5M |
| Minority Interest | $0 | $0 | $0 |
| Net to Common | $-4.5M | $-2.2M | $2.5M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Current Assets | $35.0M | $27.7M | $26.1M |
| Cash & Equivalents | $13.8M | $7.7M | $11.4M |
| Accounts Receivable | $218.0K | $91.0K | $19.0K |
| Inventory | $14.7M | $14.5M | $10.4M |
| Prepaid Expenses | $2.4M | $1.8M | $1.8M |
| Other Current Assets | $3.8M | $3.5M | $2.5M |
| Long-Term Assets | $14.2M | $13.5M | $9.9M |
| PP&E (Net) | $3.8M | $4.1M | $2.9M |
| Operating Leases | $4.6M | $3.3M | $2.1M |
| Other LT Assets | $5.8M | $6.1M | $5.0M |
| Total Assets | $49.1M | $41.2M | $36.1M |
| Current Liabilities | $29.8M | $25.8M | $20.9M |
| Accounts Payable | $4.4M | $4.0M | $2.1M |
| Current Leases | $1.6M | $1.7M | $1.2M |
| Other Current Liab | $16.4M | $13.3M | $13.8M |
| Long-Term Liabilities | $5.1M | $4.9M | $6.5M |
| LT Operating Leases | $4.2M | $2.6M | $1.6M |
| Other LT Liab | $914.0K | $2.3M | $5.0M |
| Total Liabilities | $35.0M | $30.7M | $27.4M |
| Shareholders' Equity | $14.2M | $10.5M | $8.6M |
| Paid-In Capital | $33.4M | $33.3M | $33.0M |
| Retained Earnings | $1.7M | $-1.3M | $1.2M |
| AOCI | $-208.0K | $-1.0M | $-5.7M |
| Treasury Stock | $20.7M | $20.5M | $19.9M |
| Total L&E | $49.1M | $41.2M | $36.1M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Net Income (CFO) | $-4.5M | $-2.2M | $2.5M |
| Non-Cash Adjustments | $2.4M | $5.0M | $12.5M |
| Working Capital Changes | $-466.0K | $-5.2M | $-12.7M |
| Cash from Operations | $-2.6M | $-2.4M | $2.3M |
| Capital Expenditures | $1.1M | $748.0K | $297.0K |
| Cash from Investing | $-1.1M | $-747.0K | $-285.0K |
| Share Buybacks | $2.0M | $176.0K | $0 |
| Dividends Paid | $1.5M | $748.0K | $0 |
| Cash from Financing | $-4.3M | $-1.9M | $2.0M |
| FX Effect | $-2.4M | $-790.0K | $-809.0K |
| Net Change in Cash | $-10.4M | $-5.8M | $3.1M |
| Beginning Cash | $25.6M | $15.2M | $9.4M |
| Ending Cash | $15.2M | $9.4M | $12.5M |
Frequently Asked Questions
How does MANNATECH INC make money?
Revenue is driven by four primary segments: Nutritional Supplements which includes vitamins, minerals, and herbs; Sports Nutrition featuring protein powders and performance enhancers; Organic Foods covering healthy snacks and pantry staples; and Personal Care products including skincare and oral hygiene items derived from the company's wellness ecosystem.
What are the main risks for MTEX?
Fluctuations in raw material costs for key ingredients like vitamins and botanicals could compress margins if not managed through effective hedging or price adjustments. Intense competition from established national brands and emerging private label entrants may erode market share and pricing power in saturated categories. Regulatory changes regarding supplement labeling and safety standards pose potential compliance risks that could impact product availability or incur costly recalls. Overreliance on a limited number of high-volume SKUs exposes the company to supply chain disruptions for specific ingredients.
What is MTEX's competitive advantage?
The company benefits from a robust private label strategy that eliminates brand licensing fees, significantly enhancing gross margins compared to national brand competitors. Strong direct-to-consumer relationships foster high customer retention rates and allow for premium pricing power on proprietary formulations. An extensive distribution network ensures broad market penetration across retail channels and e-commerce platforms while maintaining inventory flexibility.
Related Companies
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.